Published in J Am Soc Nephrol on December 28, 2005
Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol (2008) 2.76
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2010) 2.47
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
Considerations in the statistical analysis of hemodialysis patient survival. J Am Soc Nephrol (2009) 2.18
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol (2010) 2.15
Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol (2012) 1.90
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD. Am J Kidney Dis (2015) 1.64
Multipass haemodialysis: a novel dialysis modality. Nephrol Dial Transplant (2012) 1.42
What is new in uremic toxicity? Pediatr Nephrol (2008) 1.23
Estimating residual kidney function in dialysis patients without urine collection. Kidney Int (2016) 1.20
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.07
Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol (2010) 1.02
Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol (2009) 1.00
Dialysis cannot be dosed. Semin Dial (2011) 0.98
Searching for uremic toxins. Clin J Am Soc Nephrol (2012) 0.97
Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients. J Am Soc Nephrol (2016) 0.92
An experimental and theoretical analysis of molecular separations by diffusion through ultrathin nanoporous membranes. J Memb Sci (2011) 0.91
Serum β-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.91
Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients? PLoS One (2013) 0.90
Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease. PLoS One (2012) 0.89
Approaches to uremia. J Am Soc Nephrol (2014) 0.88
Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration. Kidney Int (2015) 0.86
The MDRD equation predicts peritoneal dialysis-delivered creatinine clearances from serum creatinine. Clin J Am Soc Nephrol (2009) 0.85
Tumour markers and kidney function: a systematic review. Biomed Res Int (2014) 0.85
Effects of hemodiafiltration and high flux hemodialysis on nerve excitability in end-stage kidney disease. PLoS One (2013) 0.85
Diffusive Silicon Nanopore Membranes for Hemodialysis Applications. PLoS One (2016) 0.81
Association between free light chain levels, and disease progression and mortality in chronic kidney disease. Toxins (Basel) (2013) 0.80
Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol. BMC Nephrol (2012) 0.80
Role of β2-microglobulin in uremic patients may be greater than originally suspected. World J Nephrol (2015) 0.79
Post-dilution on line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients. ScientificWorldJournal (2013) 0.79
Silicon nanoporous membranes as a rigorous platform for validation of biomolecular transport models. J Memb Sci (2017) 0.79
Optimizing haemodialysate composition. Clin Kidney J (2015) 0.78
Hemodiafiltration: the addition of convective flow to hemodialysis. Pediatr Nephrol (2011) 0.78
Optimization of the convection volume in online post-dilution haemodiafiltration: practical and technical issues. Clin Kidney J (2015) 0.77
HEMO Revisited: Why Kt/Vurea Only Tells Part of the Story. J Am Soc Nephrol (2016) 0.77
Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico. PLoS One (2016) 0.77
High-quality dialysis: a lesson from the Japanese experience: Effects of membrane material on nutritional status and dialysis-related symptoms. NDT Plus (2010) 0.76
Dialyzer Reuse and Outcomes of High Flux Dialysis. PLoS One (2015) 0.76
Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma. Medicine (Baltimore) (2015) 0.76
Predicting one-year mortality in peritoneal dialysis patients: an analysis of the china peritoneal dialysis registry. Int J Med Sci (2015) 0.75
Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis (2016) 0.75
The impact of high-flux dialysis on mortality rates in incident and prevalent hemodialysis patients. Korean J Intern Med (2014) 0.75
Association between plasma Beta-2 microglobulin level and cardiac performance in patients with chronic kidney disease. Nephrourol Mon (2014) 0.75
The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol (2017) 0.75
Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function. PLoS One (2014) 0.75
Dialysis membrane: from convection to adsorption. NDT Plus (2010) 0.75
Chronic Hemodialysis Therapy in the West. Kidney Dis (Basel) (2015) 0.75
Monitoring of hemodialysis quality-of-care indicators: why is it important? BMC Nephrol (2013) 0.75
Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial. Am J Transplant (2017) 0.75
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Front Med (Lausanne) (2017) 0.75
The effect of albumin leakage in hemodialysis patients on redox status of serum albumin. J Artif Organs (2016) 0.75
Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry. PLoS One (2017) 0.75
Enhancing dialyser clearance-from target to development. Pediatr Nephrol (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect (2005) 10.66
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J (2004) 7.02
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med (2008) 3.72
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int (2003) 3.54
Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis (2007) 3.53
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46
Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant (2008) 3.41
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30